Epilepsy Monitoring Devices Market
PUBLISHED: 2023 ID: SMRC24061
SHARE
SHARE

Epilepsy Monitoring Devices Market

Epilepsy Monitoring Devices Market Forecasts to 2030 - Global Analysis By Product (Conventional Devices and Wearable Devices), Type, Technology, Patient Type, Distribution Channel, End User and By Geography

4.4 (66 reviews)
4.4 (66 reviews)
Published: 2023 ID: SMRC24061

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Epilepsy Monitoring Devices Market is accounted for $556.7 million in 2023 and is expected to reach $876.5 million by 2030 growing at a CAGR of 6.7% during the forecast period. Epilepsy is a neurological ailment marked by recurring seizures, and epilepsy monitoring devices are instruments and technology used in medicine to identify, track, and manage the condition. These tools are essential for the early detection and management of epilepsy, as well as for enhancing the quality of life for those who have the condition. With the help of this portable EEG gadget, patients may be monitored while going about their daily business. It aids in catching seizures that might not happen while you're in the hospital and it includes implanting electrodes into the brain to capture brain activity in people with drug-resistant epilepsy. When non-invasive EEG techniques don't yield enough details, it's employed.

According to the World Health Organization's February 2022 update, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally

Market Dynamics:

Driver:

Growing prevalence of epilepsy

The need for epilepsy monitoring equipment grows along with the number of people who have the condition. To successfully manage their illness, a growing patient population needs additional diagnostic and monitoring instruments. Moreover, the need for therapy optimization results from a growing patient population. In order to ensure that the best therapies are employed and that the correct quantities of pharmaceuticals are provided, monitoring devices assist healthcare providers in customizing treatment regimens to each patient and combat the rising frequency of epilepsy, governmental organizations and medical institutions frequently develop public health campaigns. These initiatives can concentrate on enhancing accessibility to monitoring and diagnosing services thus propel the market growth.

Restraint:

Limited access due to high cost

Access to epilepsy monitoring equipment may be hampered by high expenses, especially for individuals without sufficient insurance or financial resources. This may result in inadequate or delayed diagnosis and care. Patients who are required to pay a substantial amount of the cost of monitoring equipment could experience financial difficulties. This can deter individuals from getting the essential diagnostic procedures or medical care. The expensive expense of monitoring equipment may completely prohibit their adoption in areas with little resources, such as poor nations, leaving people with epilepsy underserved thus hamper the market growth.

Opportunity:

Ability to change flow rates and reach high pressure

Real-time data analysis, additional monitoring channels, and enhanced signal processing are all features of digital EEG systems. More electrodes are used in high-density EEG systems to record brain activity. These devices offer more precise geographical data, which is useful for locating the source of seizures and more accurately describing epileptic activity. Monitoring has become less obtrusive and more user-friendly because to the miniaturization of monitoring equipment, such as wearable EEG headsets. Patients typically find these gadgets to be more comfortable and less bulky to wear. Together, these developments lead to more precise diagnoses, better patient care, and more effective management of epilepsy.

Threat:

Technical complexity of epilepsy monitoring devices

The adoption of very complicated monitoring devices can be constrained because healthcare providers might be reluctant to spend money on equipment that needs intensive training and continuing technical assistance. To operate and analyze data from complicated equipment, healthcare personnel require specific training and result in lengthy training times and a staffing scarcity. The accuracy and dependability of monitoring findings may be jeopardized by human mistakes, which are made more likely by technical complexity and healthcare institutions may postpone or avoid deploying complicated monitoring solutions.

Covid-19 Impact

Epilepsy monitoring and diagnosis were among the healthcare services that were disrupted by the epidemic. In order to make room for COVID-19 patients, elective procedures including certain diagnostic tests were postponed or cancelled. This had an effect on how epilepsy was identified and treated. Healthcare practitioners started using telehealth services, such as virtual consultations, to reduce in-person visits. Telehealth made it possible to remotely monitor epilepsy patients and modify treatment strategies; often negating the need for physical monitoring equipment. During the pandemic, patients with epilepsy may have had delays in seeking a diagnosis or treatment. Once healthcare services resume regular operations, this might result in a backlog of patients and increased need for epilepsy monitoring.

The conventional devices segment is expected to be the largest during the forecast period

The conventional devices segment is estimated to have a lucrative growth, due to its efficiency and safety, the market is projected to be dominated by the traditional devices segment. The term "conventional devices" refers to equipment used to continuously monitor patients using electroencephalograms (EEG). Conventional equipment is also commonly utilized in hospitals and clinics for on-going monitoring. Professionals can accurately diagnose the kind of seizure to provide the best course of therapy using conventional technology. These elements can be linked to the rising need for continuous, non-invasive epilepsy monitoring. The availability of such cutting-edge items on the market also aids in the segment's expansion.

The deep brain stimulation segment is expected to have the highest CAGR during the forecast period

The deep brain stimulation segment is anticipated to witness the highest CAGR growth during the forecast period, as deep brain stimulation (DBS) has been mainly employed to treat movement disorders including Parkinson's disease and essential tremor. It has also been investigated as a possible epileptic therapy option, particularly in situations of drug-resistant epilepsy where other therapies have failed. Although DBS is not a typical epilepsy monitoring technology, it does contribute to the overall picture of epilepsy therapy. A thorough monitoring and assessment are required before contemplating DBS as a therapy for epilepsy. EEG (electroencephalogram) and video-EEG monitoring are two types of epilepsy monitoring tools used to capture and examine a patient's brain activity during seizures.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the main drivers of the expansion of epilepsy monitoring devices in the United States are the high prevalence of neurological illnesses, particularly epilepsy, and the sheer volume of end users. Moreover, due to the rising prevalence of epilepsy, there is an increased need for epilepsy monitoring equipment in order to treat patients effectively. Additionally, it is anticipated that the market in this area would expand faster due to the presence of the key industry players there and their heavy investment in product development and research. The studied market is therefore anticipated to increase in the North American area as a result of the aforementioned aspects.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the rising epilepsy prevalence, rising awareness of neurological diseases, and improvements in medical technology. Long-term video-EEG monitoring with epilepsy monitoring equipment has been done in medical settings. Additionally, several gadgets were made to be used at home, making it easier for patients to keep an eye on their health. Monitoring devices were used as a result of rising epilepsy and associated condition awareness as well as the development of the healthcare system. This was especially true in nations with healthcare systems that were expanding quickly.

Key players in the market

Some of the key players profiled in the Epilepsy Monitoring Devices Market include Abbott Laboratories, Bioserenity, Boston Scientific Corporation, Brain Sentinel Inc., Cadwell industries, Compumedics USA inc, Emfit Corporation, Empatica Inc, Epilert, General Electric company, Kninklijke Philips N.V., Masimo, Medpage Ltd, Medtronic, Natus Medical Incorporated, Neurosoft, Neurowave systems, Nihon Kohden Corporation, Nonin and Pulse Guard International Ltd.

Key Developments:

In September 2023, Abbott announced that it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

In August 2023, Cadwell Launches Sierra NMUS1 Ultrasound and Sierra 4 Software. The new Sierra NMUS1 offers high-resolution neuromuscular and musculoskeletal ultrasound, and needle guidance capabilities, with integrated controls.

Products Covered:
• Conventional Devices
• Wearable Devices

Types Covered:
• Generalized Seizures
• Focal Seizures

Technologies Covered:
• Deep Brain Stimulation
• Accelometry
• Responsive Neurostimulation
• Vagus Nerve Stimulation
• Other Technologies

Patient Types Covered:
• Geriatric
• Adults
• Paediatric

Distribution Channels Covered:
• Online Sales
• Retail Sales
• Direct Tenders
• Other Distribution Channels

End Users Covered:
• Hospitals
• Ambulatory Services
• Neurology Centers
• Diagnostic Centers
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Epilepsy Monitoring Devices Market, By Product
5.1 Introduction
5.2 Conventional Devices
5.2.1 Monitoring Devices
5.2.1.1 Electroencephalogram (EEG) Devices
5.2.1.1.1 Standard Electroencephalogram (EEG) Devices
5.2.1.1.2 Video Electroencephalogram (EEG) Devices
5.2.1.1.3 Other/Ambulatory EEG Devices
5.2.1.2 Electromyography (EMG) Devices
5.2.1.3 Magnetoencphalography (MEG) Devices
5.2.1.4 Other Monitoring Devices
5.2.2 Deep Brain Stimulation Devices
5.3 Wearable Devices

6 Global Epilepsy Monitoring Devices Market, By Type
6.1 Introduction
6.2 Generalized Seizures
6.3 Focal Seizures

7 Global Epilepsy Monitoring Devices Market, By Technology
7.1 Introduction
7.2 Deep Brain Stimulation
7.3 Accelometry
7.4 Responsive Neurostimulation
7.5 Vagus Nerve Stimulation
7.6 Other Technologies

8 Global Epilepsy Monitoring Devices Market, By Patient Type
8.1 Introduction
8.2 Geriatric
8.3 Adults
8.4 Paediatric

9 Global Epilepsy Monitoring Devices Market, By Distribution Channel
9.1 Introduction
9.2 Online Sales
9.3 Retail Sales
9.4 Direct Tenders
9.5 Other Distribution Channels

10 Global Epilepsy Monitoring Devices Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Ambulatory Services
10.4 Neurology Centers
10.5 Diagnostic Centers
10.6 Other End Users

11 Global Epilepsy Monitoring Devices Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Abbott Laboratories
13.2 Bioserenity
13.3 Boston Scientific Corporation
13.4 Brain Sentinel Inc.
13.5 Cadwell industries
13.6 Compumedics USA inc
13.7 Emfit Corporation
13.8 Empatica Inc
13.9 Epilert
13.10 General Electric company
13.11 Kninklijke Philips N.V.
13.12 Masimo
13.13 Medpage Ltd
13.14 Medtronic
13.15 Natus Medical Incorporated
13.16 Neurosoft
13.17 Neurowave systems
13.18 Nihon Kohden Corporation
13.19 Nonin
13.20 Pulse Guard International Ltd.

List of Tables
1 Global Epilepsy Monitoring Devices Market Outlook, By Region (2021-2030) ($MN)
2 Global Epilepsy Monitoring Devices Market Outlook, By Product (2021-2030) ($MN)
3 Global Epilepsy Monitoring Devices Market Outlook, By Conventional Devices (2021-2030) ($MN)
4 Global Epilepsy Monitoring Devices Market Outlook, By Monitoring Devices (2021-2030) ($MN)
5 Global Epilepsy Monitoring Devices Market Outlook, By Electroencephalogram (EEG) Devices (2021-2030) ($MN)
6 Global Epilepsy Monitoring Devices Market Outlook, By Standard Electroencephalogram (EEG) Devices (2021-2030) ($MN)
7 Global Epilepsy Monitoring Devices Market Outlook, By Video Electroencephalogram (EEG) Devices (2021-2030) ($MN)
8 Global Epilepsy Monitoring Devices Market Outlook, By Other/Ambulatory EEG Devices (2021-2030) ($MN)
9 Global Epilepsy Monitoring Devices Market Outlook, By Electromyography (EMG) Devices (2021-2030) ($MN)
10 Global Epilepsy Monitoring Devices Market Outlook, By Magnetoencphalography (MEG) devices (2021-2030) ($MN)
11 Global Epilepsy Monitoring Devices Market Outlook, By Other Monitoring Devices (2021-2030) ($MN)
12 Global Epilepsy Monitoring Devices Market Outlook, By Deep Brain Stimulation Devices (2021-2030) ($MN)
13 Global Epilepsy Monitoring Devices Market Outlook, By Wearable Devices (2021-2030) ($MN)
14 Global Epilepsy Monitoring Devices Market Outlook, By Type (2021-2030) ($MN)
15 Global Epilepsy Monitoring Devices Market Outlook, By Generalized Seizures (2021-2030) ($MN)
16 Global Epilepsy Monitoring Devices Market Outlook, By Focal Seizures (2021-2030) ($MN)
17 Global Epilepsy Monitoring Devices Market Outlook, By Technology (2021-2030) ($MN)
18 Global Epilepsy Monitoring Devices Market Outlook, By Deep Brain Stimulation (2021-2030) ($MN)
19 Global Epilepsy Monitoring Devices Market Outlook, By Accelometry (2021-2030) ($MN)
20 Global Epilepsy Monitoring Devices Market Outlook, By Responsive Neurostimulation (2021-2030) ($MN)
21 Global Epilepsy Monitoring Devices Market Outlook, By Vagus Nerve Stimulation (2021-2030) ($MN)
22 Global Epilepsy Monitoring Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
23 Global Epilepsy Monitoring Devices Market Outlook, By Patient Type (2021-2030) ($MN)
24 Global Epilepsy Monitoring Devices Market Outlook, By Geriatric (2021-2030) ($MN)
25 Global Epilepsy Monitoring Devices Market Outlook, By Adults (2021-2030) ($MN)
26 Global Epilepsy Monitoring Devices Market Outlook, By Paediatric (2021-2030) ($MN)
27 Global Epilepsy Monitoring Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
28 Global Epilepsy Monitoring Devices Market Outlook, By Online Sales (2021-2030) ($MN)
29 Global Epilepsy Monitoring Devices Market Outlook, By Retail Sales (2021-2030) ($MN)
30 Global Epilepsy Monitoring Devices Market Outlook, By Direct Tenders (2021-2030) ($MN)
31 Global Epilepsy Monitoring Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
32 Global Epilepsy Monitoring Devices Market Outlook, By End User (2021-2030) ($MN)
33 Global Epilepsy Monitoring Devices Market Outlook, By Hospitals (2021-2030) ($MN)
34 Global Epilepsy Monitoring Devices Market Outlook, By Ambulatory Services (2021-2030) ($MN)
35 Global Epilepsy Monitoring Devices Market Outlook, By Neurology Centers (2021-2030) ($MN)
36 Global Epilepsy Monitoring Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
37 Global Epilepsy Monitoring Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

List of Figures
Figure 1 Global Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 2 North America Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 3 US Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 4 Canada Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 6 Europe Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 7 Germany Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 8 UK Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 9 Italy Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 10 France Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 11 Spain Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 14 Japan Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 15 China Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 16 India Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 17 Australia Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 21 South America Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 24 Chile Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 28 UAE Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Epilepsy Monitoring Devices Market Outlook (2021-2030) ($MN)

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials